NIH study finds omalizumab relieves seasonal asthma attacks in youth
Thursday, March 17, 2011 - 15:31
in Health & Medicine
A drug that targets the antibody immunoglobulin E (IgE), a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments, a clinical trial sponsored by the National Institutes of Health has found...